United States · FDA National Drug Code directory
Durvalumab
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61434-038_3c3ec5cf-219d-e569-e063-6394a90a464d
- Product NDC
- 61434-038
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Durvalumab
- Labeler
- Catalent Indiana, LLC
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20170501
- Source listing expiry
- 20261231
Source-listed ingredients
- DURVALUMAB — 120 mg/2.4mL
These values do not establish equivalence or a dose recommendation.
Packages
- 288 VIAL in 1 CASE (61434-038-02) / 2.4 mL in 1 VIAL · 61434-038-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →